Short answer · Medically reviewed summary · Last updated: 2026-05-08
Norrie disease is an ultra-rare, X-linked genetic disorder with an estimated prevalence of approximately 1 in 100,000 to 1 in 250,000 live male births. Because it is a rare condition, true global prevalence remains difficult to determine, and current figures likely underestimate the actual number of affected individuals due to diagnostic challenges. How is Norrie disease inherited and who does it affect? Norrie disease primarily affects males because it is caused by mutations in the NDP gene located on the X chromosome.
What is the prevalence of Norrie Disease?
Prevalence of Norrie Disease: how many people are affected worldwide, differences by sex and region, with sources.
Norrie disease is an ultra-rare, X-linked genetic disorder with an estimated prevalence of approximately 1 in 100,000 to 1 in 250,000 live male births. Because it is a rare condition, true global prevalence remains difficult to determine, and current figures likely underestimate the actual number of affected individuals due to diagnostic challenges.
How is Norrie disease inherited and who does it affect?
Norrie disease primarily affects males because it is caused by mutations in the NDP gene located on the X chromosome. While females are typically asymptomatic carriers, they can pass the gene to their children. Due to this X-linked recessive inheritance pattern, clinical manifestations are almost exclusively seen in males. Across the global DiseaseMaps community, 22 people with Norrie disease have joined to share their unique experiences, highlighting the importance of community-driven data for such a rare condition.
What is the age of onset for Norrie disease?
The onset of Norrie disease is typically congenital or occurs in early infancy. Most infants present with leukocoria (a white pupillary reflex) shortly after birth, which is a hallmark sign of the retinal detachment and vascular abnormalities associated with the disorder. Because the primary symptoms are present from birth or early childhood, it is classified as a pediatric-onset condition.
Why is accurate prevalence data for Norrie disease challenging?
Obtaining precise epidemiological data for Norrie disease is complex for several reasons:
- Underdiagnosis: Symptoms can be mistaken for other pediatric eye conditions, such as retinopathy of prematurity.
- Genetic Heterogeneity: Limited access to genetic testing in some regions prevents definitive confirmation.
- Variable Expressivity: The severity of systemic symptoms, such as sensorineural hearing loss and cognitive impairment, may vary, leading to different clinical labels.
Are there geographic or ethnic variations in prevalence?
There is no evidence to suggest that Norrie disease is more prevalent in specific ethnic groups or geographic regions. As a rare genetic disorder, it occurs sporadically worldwide, and its rarity means that large-scale epidemiological studies are limited. The global nature of the DiseaseMaps community reflects this, with affected individuals located in various countries.
Next steps
- Consult with a clinical geneticist to discuss NDP gene testing and family planning.
- Connect with the DiseaseMaps.org community to share experiences with others living with Norrie disease.
- Seek specialized care from a pediatric ophthalmologist familiar with X-linked retinal disorders.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet (ORPHA:650): Norrie disease.
- NIH Genetic and Rare Diseases (GARD) Information Center: Norrie disease.
- OMIM (Online Mendelian Inheritance in Man): Entry #310600.
- National Eye Institute (NEI): Research on retinal development and NDP-related disorders.
